Table 1

Baseline clinical characteristics of subjects

Groups

Placebo

GCE

EGML


N (male: female)

29(15:14)

29(15:14)

28(16:12)

Age (y)

33.80 ± 2.97

34.07 ± 2.30

34.96 ± 2.42

Height (cm)

169.63 ± 2.84

167.17 ± 1.58

167.95 ± 1.78

Body weight (kg)

74.03 ± 3.03

71.09 ± 2.06

72.34 ± 1.92

BMI (kg/m2)

25.53 ± 0.43

25.29 ± 0.36

25.25 ± 0.37

Systolic BP (mmHg)

122.57 ± 4.49

125.69 ± 53

123.38 ± 4.02

Diasolic BP (mmHg)

76.85 ± 2.65

74.11 ± 3.66

75.45 ± 3.84

FBG (mg/dL)

90.04 ± 2.58

93.97 ± 3.44

88.73 ± 4.07

Waist (inch)

33.43 ± 0.69

32.43 ± 0.60

33.49 ± 0.61

Hip (inch)

39.49 ± 0.47

39.10 ± 0.42

39.54 ± 0.41


Values are mean ± S.E.; GCE, Garcinia cambogia extract; EGML, Extract of Glycine max leaves; FBG, fasting blood glucose

Kim et al. Nutrition Journal 2011 10:94   doi:10.1186/1475-2891-10-94

Open Data